September 2 - 3, 2020


Converge. Create. Elevate.


Senior VP, Development Sciences, Genentech


Sara Kenkare-Mitra PhD is currently Senior Vice President of Development Sciences, a translational sciences organization that spans R&D at Genentech. In this role she has responsibility for ensuring the successful translation of promising molecule-discoveries from Research into Development. Additionally, over the last decade, her team has been the drivers of personalization of treatments through innovative biomarkers, diagnostics and personalized dosing regimens in R&D at Genentech and Roche.

Sara and her team have had a significant impact on the development of a number of biologics and small molecules leading to Genentech's key product approvals including Avastin, Tarceva, Lucentis, Xolair, Erivedge, Perjetta, Kadcyla, Venetoclax, Cobimetinib, Esbriet, Hemlibra, Alecensa, Ocrevus, Tecentriq and Polivy. In addition, more than 80 Investigational New Drug applications with potential to treat a multitude of diseases in particular cancer, have been filed by her organization with US and ex-US regulatory agencies. At Genentech she is a key member of the technical and portfolio decision making committees. Sara also holds adjunct faculty positions at UCSF in the Department of Bioengineering and Therapeutic Sciences and the University of the Pacific in Stockton.

Sara was elected to the Institute of Medicine, National Academy (NAM) in 2014 and to the American Association for the advancement of Science (AAAS) fellow in 2019. Selected as one of the 150 Most Influential Business women by San Francisco Business times in 2011, one of the 150 top alumni of UCSF in 2015, UCSF Distinguished Alumni 2018, Fiercest women in Life sciences 2018 she has also won awards and recognition at Genentech not only for her excellence in leadership and mentorship, but also for her passionate commitment to the healthcare industry as a whole. Sara serves on the board of directors of the Genentech foundation, a US based private charitable foundation and also on the board of the Association for women in science (AWIS).

In addition Sara is a passionate advocate for STEM education, women in Science and the cause of people with developmental disabilities.